vs
Side-by-side financial comparison of Vita Coco Company, Inc. (COCO) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $179.8M, roughly 1.6× Vita Coco Company, Inc.). Vita Coco Company, Inc. runs the higher net margin — 17.0% vs 12.8%, a 4.1% gap on every dollar of revenue. On growth, Vita Coco Company, Inc. posted the faster year-over-year revenue change (37.3% vs -6.4%). Over the past eight quarters, Vita Coco Company, Inc.'s revenue compounded faster (11.7% CAGR vs 4.2%).
The Vita Coco Company, doing business simply as Vita Coco, is an American beverage company which mainly sells coconut water. The largest brand globally in coconut/plant waters, Vita Coco has operations in 31 countries as of 2016. It is a benefit corporation. The company is owned by All Market Inc.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
COCO vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $179.8M | $295.9M |
| Net Profit | $30.5M | $38.0M |
| Gross Margin | 39.9% | 64.6% |
| Operating Margin | 18.7% | 18.4% |
| Net Margin | 17.0% | 12.8% |
| Revenue YoY | 37.3% | -6.4% |
| Net Profit YoY | 61.4% | 68.3% |
| EPS (diluted) | $0.50 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $179.8M | — | ||
| Q4 25 | $127.8M | $295.9M | ||
| Q3 25 | $182.3M | — | ||
| Q2 25 | $168.8M | $317.0M | ||
| Q1 25 | $130.9M | $316.2M | ||
| Q4 24 | $127.3M | $297.0M | ||
| Q3 24 | $132.9M | $289.5M | ||
| Q2 24 | $144.1M | $306.1M |
| Q1 26 | $30.5M | — | ||
| Q4 25 | $5.5M | $38.0M | ||
| Q3 25 | $24.0M | — | ||
| Q2 25 | $22.9M | $-17.7M | ||
| Q1 25 | $18.9M | $22.6M | ||
| Q4 24 | $3.4M | $34.9M | ||
| Q3 24 | $19.3M | $33.6M | ||
| Q2 24 | $19.1M | $40.6M |
| Q1 26 | 39.9% | — | ||
| Q4 25 | 34.9% | 64.6% | ||
| Q3 25 | 37.7% | — | ||
| Q2 25 | 36.3% | 62.7% | ||
| Q1 25 | 36.7% | 67.9% | ||
| Q4 24 | 32.5% | 65.3% | ||
| Q3 24 | 38.8% | 63.2% | ||
| Q2 24 | 40.8% | 66.4% |
| Q1 26 | 18.7% | — | ||
| Q4 25 | 8.0% | 18.4% | ||
| Q3 25 | 15.3% | — | ||
| Q2 25 | 14.9% | -7.5% | ||
| Q1 25 | 14.7% | 12.2% | ||
| Q4 24 | 3.4% | 16.0% | ||
| Q3 24 | 15.5% | 13.8% | ||
| Q2 24 | 20.8% | 15.0% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 4.3% | 12.8% | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | 13.6% | -5.6% | ||
| Q1 25 | 14.4% | 7.1% | ||
| Q4 24 | 2.6% | 11.7% | ||
| Q3 24 | 14.5% | 11.6% | ||
| Q2 24 | 13.2% | 13.3% |
| Q1 26 | $0.50 | — | ||
| Q4 25 | $0.10 | $0.24 | ||
| Q3 25 | $0.40 | — | ||
| Q2 25 | $0.38 | $-0.11 | ||
| Q1 25 | $0.31 | $0.14 | ||
| Q4 24 | $0.06 | $0.22 | ||
| Q3 24 | $0.32 | $0.21 | ||
| Q2 24 | $0.32 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $201.9M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $352.2M | $2.0B |
| Total Assets | $488.3M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $201.9M | — | ||
| Q4 25 | $196.9M | $172.9M | ||
| Q3 25 | $203.7M | — | ||
| Q2 25 | $167.0M | $162.2M | ||
| Q1 25 | $153.6M | $140.7M | ||
| Q4 24 | $164.7M | $177.5M | ||
| Q3 24 | $156.7M | $187.5M | ||
| Q2 24 | $150.1M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M |
| Q1 26 | $352.2M | — | ||
| Q4 25 | $331.5M | $2.0B | ||
| Q3 25 | $323.7M | — | ||
| Q2 25 | $296.9M | $1.9B | ||
| Q1 25 | $277.9M | $2.0B | ||
| Q4 24 | $258.8M | $2.1B | ||
| Q3 24 | $252.1M | $2.1B | ||
| Q2 24 | $232.0M | $2.1B |
| Q1 26 | $488.3M | — | ||
| Q4 25 | $461.2M | $2.5B | ||
| Q3 25 | $461.3M | — | ||
| Q2 25 | $421.1M | $2.6B | ||
| Q1 25 | $384.0M | $2.6B | ||
| Q4 24 | $362.4M | $2.7B | ||
| Q3 24 | $353.1M | $2.7B | ||
| Q2 24 | $323.0M | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COCO
| Subtotal | $148.2M | 82% |
| Private Label | $24.4M | 14% |
| Other | $7.2M | 4% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
